Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Day One Biopharmaceuticals, Inc. (DAWN) had Current Ratio of 8.68 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$39.80M |
|
$-19.73M |
|
$4.48M |
|
$35.31M |
|
$64.05M |
|
$-24.25M |
|
$4.53M |
|
$-19.73M |
|
$-19.73M |
|
$-19.73M |
|
$-19.73M |
|
$-19.73M |
|
$-19.73M |
|
$-24.25M |
|
$-23.32M |
|
103.38M |
|
103.38M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$489.97M |
|
$2.23M |
|
$23.81M |
|
$513.78M |
|
$56.47M |
|
-- |
|
$6.45M |
|
$62.91M |
|
$450.87M |
|
$432.05M |
|
$450.87M |
|
102.68M |
|
| Cash Flow Statement Financials | |
$-89.61M |
|
$7.17M |
|
$0.75M |
|
$124.97M |
|
$43.28M |
|
$-81.69M |
|
$33.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
8.68 |
-- |
|
-- |
|
-- |
|
-- |
|
88.74% |
|
-60.94% |
|
-60.94% |
|
-- |
|
-49.57% |
|
-49.57% |
|
$-89.90M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.63 |
|
2.38 |
|
37.76 |
|
-4.38% |
|
-4.57% |
|
-3.84% |
|
-4.38% |
|
$4.39 |
|
$-0.87 |
|
$-0.87 |
|